SavedAdd your journal

Journals / Haseki Tıp Bülteni / 2014 / Cilt: 52 - Sayı: 4

Lung Damage due to Chemotherapeutic Agents

Kemoterapötik Ajanlara Bağlı Oluşan Akciğer Hasarı

Serdar KALEMCİ
Çağdaş CAN
Hamdi SÖZEN
Pages
248–250
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Combined administration of many drugs, concurrent radiotherapy applications, opportunistic infections, lymphangitic tumor extension and pleural metastases complicate the disease diagnosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Chemotherapeutic drug-induced pulmonary toxicity not only emerges in cumulative doses, but also can be observed even at low dosages.
📊
Key Findings & Data:Chemotherapeutic drug-induced pulmonary toxicity not only emerges in cumulative doses, but also can be observed even at low dosages.
💡
Conclusion & Impact:Combined administration of many drugs, concurrent radiotherapy applications, opportunistic infections, lymphangitic tumor extension and pleural metastases complicate the disease diagnosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Chemotherapeutic drug-induced pulmonary toxicity not only emerges in cumulative doses, but also can be observed even at low dosages. Combined administration of many drugs, concurrent radiotherapy applications, opportunistic infections, lymphangitic tumor extension and pleural metastases complicate the disease diagnosis.

Özet

Kemoterapötik ilaçlara bağlı gelişen pulmoner toksisite kümülatif dozlarda ortaya çıkarken düşük dozlarda dahi gözlenebilmektedir. Bir çok ilacın kombine verilmesi, eş zamanlı radyoterapi uygulamaları, fırsatçı enfeksiyonlar, lenfanjitik tümör yayılımı, plevra metastazları bu hastalığın tanısını koymayı güçleştirmektedir.

🔖

Cite This Article

KALEMCİ, S., CAN, Ç., SÖZEN, H. (2014). Lung Damage due to Chemotherapeutic Agents. Haseki Tıp Bülteni, Cilt: 52 - Sayı: 4, 248–250. https://ajindex.com/articles/267920

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Dimopoulou I, Bamias A, Lyberopoulos P, Dimopoulos MA. Pulmonary toxicity from novel antineoplastic agents. Ann Oncol 2006;17:372-79
  2. Limper AH. Chemotherapy induced lung disease. Clin Chest Med 2004;25:53-64
  3. Lazo JS, Merrill WW, Pham ET, et al. Bleomycin hydrolase activity in pulmonary cells. J Pharmacol Exp Ther 1984;231:583-8
  4. Maher J, Daly PA. Severe bleomycin lung toxicity: reversal with high dose corticosteroids. Thorax 1993;48:92-4
  5. Nici L, Santos-Moore A, Kuhn C, et al. Modulation of bleomycin-induced pulmonary toxicity in the hamster by the antioxidant amifostine. Cancer 1998;83:2008-14
  6. O'Sullivan JM, Huddart RA, Norman AR, et al. Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours. Ann Oncol 2003;14:91-6
  7. Jin X, Dai H, Ding K, et al. Rapamycin attenuates bleomycin-induced pulmonary fibrosis in rats and the expression of metalloproteinase-9 and tissue inhibitors of metalloproteinase-1 in lung tissue. Chin Med J (Engl) 2014;127:1304-9
  8. Castro M, Veeder MH, Mailliard JA, et al. A prospective study of pulmonary function in patients receiving mitomycin. Chest 1996;109:939-44
  9. Chen MY, Chiles C, Loggie BW, et al. Thoracic complications in patients undergoing intraperitoneal heated chemotherapy with mitomycin following cytoreductive surgery. J Surg Oncol 1997;66:19-23
  10. Brockstein BE, Smiley C, Al-Sadir J, et al. Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast canser: prognostic factors. Bone Marrow Transplant 2000;25:885-94
  11. Hamada K, Nagai S, Kitaichi M, et al. Cyclophosphamideinduced late-onset lung disease. Intern Med 2003;42:82-7
  12. Malik SW, Myers JL, DeRemee RA, et al. Lung Toxicity associated with cyclophosphamide use. Two distinct patterns. Am J Respir Crit Care Med 1996;154:1851-6
  13. Hoyt DG, Lazo JS. Acute pneumocyte injury, poly (ADP-ribose) polymerase activity, and pyridine nucleotide levels after in vitro exposure of murine lung slices to cyclophosphamide. Biochem Pharmacol 1994;48:1757-65
  14. Kim YJ, Song M, Ryu JC. Inflammation in methotrexateinduced pulmonary toxicity occurs via the p38 MAPK pathway. Toxicology 2009;256:183-90
  15. Forghieri F, Luppi M, Morselli M, et al. Cytarabine-related lung infiltrates on high resolution computerized tomography: a possible complication with benign outcome in leukemic patients. Haematologica 2007;92:85-90
  16. Rudzianskiene M, Griniute R, Juozaityte E et al. Corticosteroid-resp